Kintz Samuel

Enliven Therapeutics, Inc. ยท PRESIDENT AND CEO

Kintz Samuel is listed in public filings as director, officer: PRESIDENT AND CEO. This Kintz Samuel insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN). Investors use Kintz Samuel's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Enliven Therapeutics, Inc.ELVN$19M890.4k sharesSellNov 17, 2025$272.7K12.5k shares$21.82--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Enliven Therapeutics, Inc.ELVN$19M902.9k sharesSellOct 17, 2025$266.7K12.5k shares$21.33--
Enliven Therapeutics, Inc.ELVN$18M915.4k sharesSellSep 26, 2025$74.2K3.7k shares$20.06--
Enliven Therapeutics, Inc.ELVN$18M919.1k sharesSellSep 23, 2025$56.1K2.8k shares$20.03--
Enliven Therapeutics, Inc.ELVN$19M921.9k sharesSellSep 19, 2025$20.3K1k shares$20.25--
Enliven Therapeutics, Inc.ELVN$18M922.9k sharesSellSep 17, 2025$95.5K5k shares$19.09--
Enliven Therapeutics, Inc.ELVN$19M927.9k sharesSellAug 20, 2025$30.3K1.5k shares$20.00--
Enliven Therapeutics, Inc.ELVN$19M929.4k sharesSellAug 19, 2025$11.8K590 shares$20.00--
Enliven Therapeutics, Inc.ELVN$19M930k sharesSellAug 18, 2025$208.1K10.4k shares$20.02--
Enliven Therapeutics, Inc.ELVN$21M944.1k sharesSellJul 17, 2025$106.4K4.7k shares$22.69--
Enliven Therapeutics, Inc.ELVN$20M948.7k sharesSellJul 17, 2025$89.6K4.2k shares$21.58--
Enliven Therapeutics, Inc.ELVN$22M940.4k sharesSellJul 17, 2025$85.6K3.7k shares$23.37--
Enliven Therapeutics, Inc.ELVN$21M954.9k sharesSellJun 17, 2025$231.8K10.5k shares$22.08--
Enliven Therapeutics, Inc.ELVN$22M952.9k sharesSellJun 17, 2025$45.5K2k shares$22.75--
Enliven Therapeutics, Inc.ELVN$19M965.4k sharesSellJun 3, 2025$150.4K7.5k shares$20.05--
Enliven Therapeutics, Inc.ELVN$16M972.9k sharesSellMay 19, 2025$82.5K5k shares$16.49--
Enliven Therapeutics, Inc.ELVN$20M977.9k sharesSellMay 2, 2025$43.4K2.2k shares$20.00--
Enliven Therapeutics, Inc.ELVN$20M980.1k sharesSellMay 1, 2025$107.0K5.3k shares$20.08--
Enliven Therapeutics, Inc.ELVN$16M985.4k sharesSellApr 17, 2025$82.1K5k shares$16.42--
Enliven Therapeutics, Inc.ELVN$21M990.4k sharesSellMar 17, 2025$260.3K12.5k shares$20.83--
Enliven Therapeutics, Inc.ELVN$11M490k sharesGrant / ExerciseFeb 6, 2025$11.0M490k shares$22.47--
Enliven Therapeutics, Inc.ELVN$30M1M sharesSellOct 18, 2024$27.7K924 shares$30.00--
Enliven Therapeutics, Inc.ELVN$28M1M sharesSellOct 9, 2024$389.7K13.9k shares$28.07--
Enliven Therapeutics, Inc.ELVN$29M1M sharesSellOct 9, 2024$80.7K2.8k shares$28.53--
Enliven Therapeutics, Inc.ELVN$29M1M sharesSellOct 8, 2024$368.1K13.2k shares$27.95--
Enliven Therapeutics, Inc.ELVN$29M1M sharesSellOct 8, 2024$2.9K100 shares$28.51--
Enliven Therapeutics, Inc.ELVN$28M1M sharesSellOct 7, 2024$75.1K2.7k shares$27.50--
Enliven Therapeutics, Inc.ELVN$29M1M sharesSellOct 4, 2024$335.8K12.2k shares$27.51--
Enliven Therapeutics, Inc.ELVN$29M1M sharesSellOct 1, 2024$14.5K526 shares$27.54--
Enliven Therapeutics, Inc.ELVN$24M1M sharesSellAug 26, 2024$274.7K12k shares$22.89--
Enliven Therapeutics, Inc.ELVN$29M1.1M sharesSellJul 31, 2024$62.6K2.3k shares$27.56--
Enliven Therapeutics, Inc.ELVN$27M1.1M sharesSellJul 25, 2024$204.9K8.2k shares$25.10--
Enliven Therapeutics, Inc.ELVN$27M1.1M sharesSellJul 25, 2024$1.1K43 shares$25.83--
Enliven Therapeutics, Inc.ELVN$26M1.1M sharesSellJul 25, 2024$93.0K3.8k shares$24.53--
Enliven Therapeutics, Inc.ELVN$23M1.1M sharesSellJun 25, 2024$247.0K11.4k shares$21.63--
Enliven Therapeutics, Inc.ELVN$24M1.1M sharesSellJun 25, 2024$12.9K578 shares$22.30--